Reducing Antibiotic Treatment Duration for Ventilator-Associated Pneumonia: A Multicenter, Individually Randomized, Open-Label, Non-Inferiority Trial (REGARD-VAP) (Lancet Respiratory Medicine)
Back to course
Video Transcription
Video Summary
Asset Caption
One-Hour Concurrent Session | Late-Breaking Studies Affecting Patient Outcomes II
Meta Tag
Content Type Presentation
Membership Level Professional
Membership Level Select
Year 2024
Keywords
ventilator-associated pneumonia
antibiotic treatment duration
antimicrobial resistance
personalized treatment
Lancet Respiratory Medicine